{
    "2020-09-29": [
        [
            {
                "time": "",
                "original_text": "上海谊众冲刺科创板 尚无实际产品销售",
                "features": {
                    "keywords": [
                        "上海谊众",
                        "科创板",
                        "实际产品销售"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医院用药止不住下滑趋势，扬子江右美托咪定销量增长5倍",
                "features": {
                    "keywords": [
                        "医院用药",
                        "下滑趋势",
                        "扬子江",
                        "右美托咪定",
                        "销量增长"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2020年中国最具价值品牌500强排行榜报告重磅发布",
                "features": {
                    "keywords": [
                        "中国",
                        "品牌",
                        "500强",
                        "排行榜"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "扣非净利连续五年为负 海正药业经营偿债双重压力来袭怎么扛？",
                "features": {
                    "keywords": [
                        "扣非净利",
                        "海正药业",
                        "经营压力",
                        "偿债压力"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-29",
                "original_text": "9月29日主力资金净流出27亿元",
                "features": {
                    "keywords": [
                        "主力资金",
                        "净流出",
                        "27亿元"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药获得药物临床试验批准通知书、有偿许可抗肿瘤药品给韩国HLB-LS公司",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "抗肿瘤药品",
                        "韩国HLB-LS"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药抗肿瘤药吡咯替尼项目有偿许可给韩国HLB-LS公司",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "抗肿瘤药",
                        "吡咯替尼",
                        "韩国HLB-LS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "买入农业股，抛售白酒股！北向资金进入休假模式，携款10亿再度出逃",
                "features": {
                    "keywords": [
                        "农业股",
                        "白酒股",
                        "北向资金",
                        "出逃"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "专家认为医药行业长期向好",
                "features": {
                    "keywords": [
                        "专家",
                        "医药行业",
                        "长期向好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "节日效应致交投低迷 三季报预增股受追捧",
                "features": {
                    "keywords": [
                        "节日效应",
                        "交投低迷",
                        "三季报预增股"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}